@prefix dcterms: .
@prefix this: .
@prefix sub: .
@prefix beldoc: .
@prefix rdfs: .
@prefix rdf: .
@prefix xsd: .
@prefix dce: .
@prefix pav: .
@prefix np: .
@prefix belv: .
@prefix prov: .
@prefix chebi: .
@prefix go: .
@prefix Protein: .
@prefix hgnc: .
@prefix geneProductOf: .
@prefix hasAgent: .
@prefix hasAnnotation: .
@prefix species: .
@prefix occursIn: .
@prefix mesh: .
@prefix pubmed: .
@prefix orcid: .
sub:Head {
this: np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo;
a np:Nanopublication .
}
sub:assertion {
sub:_1 hasAgent: sub:_2;
a go:0016301 .
sub:_2 geneProductOf: hgnc:1097;
a Protein: .
sub:_3 occursIn: mesh:D003593, species:9606;
hasAnnotation: sub:_4;
rdf:object sub:_1;
rdf:predicate belv:directlyDecreases;
rdf:subject chebi:50924;
a rdf:Statement .
sub:_4 dcterms:subject "TextLocation";
rdf:value "Review" .
sub:assertion rdfs:label "a(CHEBI:sorafenib) =| kin(p(HGNC:BRAF))" .
}
sub:provenance {
beldoc: dce:description "Approximately 2000 hand curated statements drawn from 57 PubMeds.";
dce:rights "Copyright (c) 2011-2012, Selventa. All Rights Reserved.";
dce:title "BEL Framework Small Corpus Document";
dcterms:license "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License";
pav:authoredBy sub:_6;
pav:version "1.6" .
sub:_5 prov:value """Originally identified by high-throughput screening of small molecules against C-Raf
kinase, sorafenib was found to be a potent competitive inhibitor of ATP binding
in the catalytic domains of C-Raf, wild-type B-Raf, and V599EB-Raf mutant.""";
prov:wasQuotedFrom pubmed:16170185 .
sub:_6 rdfs:comment "support@belframework.org";
rdfs:label "Selventa" .
sub:assertion prov:hadPrimarySource pubmed:16170185;
prov:wasDerivedFrom beldoc:, sub:_5 .
}
sub:pubinfo {
this: dcterms:created "2014-07-03T14:29:30.650+02:00"^^xsd:dateTime;
pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 .
}